346 related articles for article (PubMed ID: 25934595)
21. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
22. Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes.
Blazeski A; Lowenthal J; Wang Y; Teuben R; Zhu R; Gerecht S; Tomaselli G; Tung L
Tissue Eng Part A; 2019 May; 25(9-10):725-735. PubMed ID: 30520705
[TBL] [Abstract][Full Text] [Related]
23. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
24. Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes.
Paci M; Hyttinen J; Aalto-Setälä K; Severi S
Ann Biomed Eng; 2013 Nov; 41(11):2334-48. PubMed ID: 23722932
[TBL] [Abstract][Full Text] [Related]
25. Calcium and voltage mapping in hiPSC-CM monolayers.
Herron TJ
Cell Calcium; 2016 Mar; 59(2-3):84-90. PubMed ID: 26922095
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.
Wyles SP; Hrstka SC; Reyes S; Terzic A; Olson TM; Nelson TJ
Clin Transl Sci; 2016 Jun; 9(3):158-67. PubMed ID: 27105042
[TBL] [Abstract][Full Text] [Related]
27. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.
Wyles SP; Li X; Hrstka SC; Reyes S; Oommen S; Beraldi R; Edwards J; Terzic A; Olson TM; Nelson TJ
Hum Mol Genet; 2016 Jan; 25(2):254-65. PubMed ID: 26604136
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
Tanaka A; Yuasa S; Node K; Fukuda K
Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
[TBL] [Abstract][Full Text] [Related]
29. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
[TBL] [Abstract][Full Text] [Related]
30. An abnormal TRPV4-related cytosolic Ca
Lu J; Lee YK; Ran X; Lai WH; Li RA; Keung W; Tse K; Tse HF; Yao X
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2964-2972. PubMed ID: 28754452
[TBL] [Abstract][Full Text] [Related]
31. Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Pioner JM; Racca AW; Klaiman JM; Yang KC; Guan X; Pabon L; Muskheli V; Zaunbrecher R; Macadangdang J; Jeong MY; Mack DL; Childers MK; Kim DH; Tesi C; Poggesi C; Murry CE; Regnier M
Stem Cell Reports; 2016 Jun; 6(6):885-896. PubMed ID: 27161364
[TBL] [Abstract][Full Text] [Related]
32. Human Induced Pluripotent Stem Cells as a Disease Model System for Heart Failure.
Deicher A; Seeger T
Curr Heart Fail Rep; 2021 Feb; 18(1):1-11. PubMed ID: 33215357
[TBL] [Abstract][Full Text] [Related]
33. Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy.
Feyen DAM; Perea-Gil I; Maas RGC; Harakalova M; Gavidia AA; Arthur Ataam J; Wu TH; Vink A; Pei J; Vadgama N; Suurmeijer AJ; Te Rijdt WP; Vu M; Amatya PL; Prado M; Zhang Y; Dunkenberger L; Sluijter JPG; Sallam K; Asselbergs FW; Mercola M; Karakikes I
Circulation; 2021 Aug; 144(5):382-392. PubMed ID: 33928785
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
35. Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models.
Granéli C; Hicks R; Brolén G; Synnergren J; Sartipy P
Stem Cell Rev Rep; 2019 Feb; 15(1):13-22. PubMed ID: 30343468
[TBL] [Abstract][Full Text] [Related]
36. Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells.
Drawnel FM; Boccardo S; Prummer M; Delobel F; Graff A; Weber M; Gérard R; Badi L; Kam-Thong T; Bu L; Jiang X; Hoflack JC; Kiialainen A; Jeworutzki E; Aoyama N; Carlson C; Burcin M; Gromo G; Boehringer M; Stahlberg H; Hall BJ; Magnone MC; Kolaja K; Chien KR; Bailly J; Iacone R
Cell Rep; 2014 Nov; 9(3):810-21. PubMed ID: 25437537
[TBL] [Abstract][Full Text] [Related]
37. Genomic Engineering of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Cavanaugh C; Hesson J; Mathieu J
Methods Mol Biol; 2024; 2735():129-143. PubMed ID: 38038847
[TBL] [Abstract][Full Text] [Related]
38. Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells.
Jiang X; Chen Y; Liu X; Ye L; Yu M; Shen Z; Lei W; Hu S
Front Cell Dev Biol; 2021; 9():672039. PubMed ID: 34079803
[TBL] [Abstract][Full Text] [Related]
39. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
40. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
